RISK OF DEATH AFTER PACLITAXEL EXPOSURE DURING FEMOROPOPLITEAL ARTERY ANGIOPLASTY – NARRATIVE REVIEW

RISK OF DEATH AFTER PACLITAXEL EXPOSURE DURING FEMOROPOPLITEAL ARTERY ANGIOPLASTY – NARRATIVE REVIEW

Paclitaxel molecule has been on the market since 1991 and is indicated for the treatment of multiple neoplasms. Since 2012 has been used in endovascular devices for the treatment of peripheral artery disease and have become a mainstay in the treatment of symptomatic femoro-popliteal lesions, in...

Full description

Bibliographic Details
Main Authors:	Tiago F. Ribeiro, Rita Soares Ferreira, Joana Cardoso, Adriana Figueiredo, Helena Fidalgo, Frederico Bastos Gonçalves, Maria Emília Ferreira
Format:	Article
Language:	Portuguese
Published:	Sociedade Portuguesa de Angiologia e Cirurgia Vascular 2022-03-01
Series:	Angiologia e Cirurgia Vascular
Subjects:	Peripheral Artery Disease Endovascular Therapy Paclitaxel Coated Devices
Online Access:	https://acvjournal.com/index.php/acv/article/view/436

Similar Items

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Konstantinos Katsanos, et al.
Published: (2018-12-01)

Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment
by: Marianne Brodmann, et al.

Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
by: Shigemitsu Shirai, et al.
Published: (2022-09-01)

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study
by: Gérald Gahide, et al.
Published: (2021-08-01)

Paclitaxel-coated balloons angioplasties for extra-long femoropopliteal artery atherosclerotic lesions (> 30 cm):12 months outcomes from a single center
by: Tao Pan, et al.
Published: (2022-02-01)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
by: Ulf Teichgräber, et al.
Published: (2021-09-01)

Comparison of Effectiveness of Drug-Coated Balloon Angioplasty versus Plain Balloon Angioplasty in Chronic Lower Extremity Ischemia Patients
by: Nazari I, et al.
Published: (2020-09-01)

Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease
by: Herten M, et al.
Published: (2016-08-01)

A pilot study of a novel paclitaxel-coated angioplasty catheter for lower extremity peripheral artery disease: a pilot study
by: Serpil Şahin, et al.
Published: (2023-04-01)

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern
by: Takuya Tsujimura, et al.
Published: (2021-07-01)

Paclitaxel-Coated versus Uncoated Balloon for Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Qiwei Li, et al.
Published: (2022-09-01)

Algorithm of Femoropopliteal Endovascular Treatment
by: Maxime Dubosq, et al.
Published: (2022-09-01)

Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
by: Kohei Yamaguchi, et al.
Published: (2023-11-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
by: Ilka Ott, et al.
Published: (2017-07-01)

Effectiveness of Atherectomy and Drug-Coated Balloon Angioplasty in Femoropopliteal Disease: A Comprehensive Outcome Study
by: Hyeon Ju Kim, et al.
Published: (2024-09-01)

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
by: Naghi J, et al.
Published: (2016-06-01)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
by: Yoshimitsu Soga, et al.
Published: (2023-01-01)

Drug-Coated Balloons: Drugs Beyond Paclitaxel?
by: Tobias Haase, et al.
Published: (2022-10-01)

Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)

Case report: Unusual persistent hypotension and acute occlusion after peripheral paclitaxel balloon angioplasty
by: Lin Yang, et al.
Published: (2022-10-01)

Evaluation of paclitaxel-coated balloon angioplasty for the treatment of symptomatic intracranial in-stent restenosis
by: Huiyuan Xue, et al.
Published: (2024-05-01)

A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions
by: Leng Ni, et al.
Published: (2022-03-01)

Restenosis of the femoropopliteal artery after percutaneous transluminal angioplasty
by: Vladka Salapura, et al.
Published: (2014-05-01)

Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives
by: Filippo Luca Gurgoglione, et al.
Published: (2024-11-01)

Activating autophagy improves paclitaxel-induced peripheral neuropathy in chemotherapy
by: Jin Zhang, et al.
Published: (2024-10-01)

Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
by: Takuya Haraguchi, et al.
Published: (2023-05-01)

Efficacy and safety of paclitaxel drug-coated balloon angioplasty for stenosis of hemodialysis vascular access: 6-month results from a brazilian multicenter prospective study
by: Leonardo de Oliveira Harduin, et al.
Published: (2025-02-01)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
by: F Scheer, et al.
Published: (2015-04-01)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
by: F Scheer, et al.
Published: (2014-01-01)

The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty
by: Yuhao Lin, et al.
Published: (2024-09-01)

Paclitaxel-assisted balloon angioplasty of venous stenosis in haemodialysis access: PAVE RCT
by: Narayan Karunanithy, et al.
Published: (2021-09-01)

In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons
by: Emily Turner, et al.
Published: (2018-07-01)

A case of vasculitis after paclitaxel drug-coated balloon angioplasty
by: Kelly Hawkins, BS, et al.
Published: (2022-05-01)

Mid and long-term results of the Supera® stent in femoropopliteal obstructive disease: a comprehensive analysis of the literature
by: Andreia Pinelo, et al.
Published: (2024-03-01)

Angiographic and Intravascular Imaging Findings for Ultrasound Detected Aneurysmal Degeneration Following Polymer Based Paclitaxel Eluting Nitinol Stent Implantation for Femoropopliteal Artery Occlusion
by: Tatsuya Nakama, et al.
Published: (2020-01-01)

Chronic limb-threatening ischemia under the age of 50 – a single-center 12-year retrospective study
by: Inês Gueifão, et al.
Published: (2025-01-01)

The Antinociceptive Responses of MTDZ to Paclitaxel−Induced Peripheral Neuropathy and Acute Nociception in Mice: Behavioral, Pharmacological, and Biochemical Approaches
by: Ketlyn P. da Motta, et al.
Published: (2023-08-01)

Cutaneous polyarteritis nodosa resulting from a paclitaxel-eluting balloon angioplasty
by: Allison Montgomery, BA, et al.
Published: (2018-01-01)

Effect of Melatonin on Paclitaxel-Associated Acute and Chronic Pain: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Naeeme Talaee, et al.
Published: (2022-10-01)